Biomimetic Nano‐Immunoactivator via Ionic Metabolic Modulation for Strengthened NIR‐II Photothermal Immunotherapy
Small · 2023-12 · 19 (49)
DOI: 10.1002/smll.202304370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 16.08.2023. Verfasst von Xiaodan Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, and School of Life Scienc…. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Joint Funds of Center for Engineering Medicine.
Abstract (Originalsprache)
Reprogramming the immunologically “cold” environment of solid tumors is currently becoming the mainstream strategy to elicit powerful and systemic anticancer immunity. Here, a facile and biomimetic nano‐immunnoactivator ( CuS/Z@M 4T1 ) is detailed by engineering a Zn 2+ ‐bonded zeolitic imidazolate framework‐8 (ZIF‐8) with CuS nanodots (NDs) and cancer cell membrane for amplified near‐infrared‐II (NIR‐II) photothermal immunotherapy via Zn 2+ metabolic modulation. Taking advantage of the NIR‐II photothermal effect of CuS NDs and the acidic responsiveness of ZIF‐8, CuS/Z@M 4T1 rapidly causes intracellular Zn 2+ pool overload and disturbs the metabolic flux of 4T1 cells, which effectively hamper the production of heat shock proteins and relieve the resistance of photothermal therapy (PTT). Thus, amplified immunogenic cell death is evoked and initiates the immune cascade both in vivo and in vitro as demonstrated by dendritic cells maturation and T‐cell infiltration. Further combination with antiprogrammed death 1 (aPD‐1) achieves escalated antitumor efficacy which eliminates the primary, distant tumor and avidly inhibits lung metastasis due to cooperation of enhanced photothermal stimulation and empowerment of cytotoxic T lymphocytes by aPD‐1. Collectively, this work provides the first report of using the intrinsic modulation property of meta‐organometallic ZIF‐8 for enhanced cancer photoimmunotherapy together with aPD‐1, thereby inspiring a novel combined paradigm of ion‐rich nanomaterials for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of C…
- TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, No. 39 Shi-er-qiao Road, Chengdu, Sichuan, 610072, P. R. China.
ORCID-Profile: Yiyao Liu
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- Joint Funds of Center for Engineering Medicine
Zitieren
APA
Wei, X., Huang, H., Guo, J., Li, N., Li, Q., Zhao, T., Yang, G., Cai, L., Yang, H., Wu, C., & Liu, Y. (2023). Biomimetic Nano‐Immunoactivator via Ionic Metabolic Modulation for Strengthened NIR‐II Photothermal Immunotherapy. Small, 19(49). https://doi.org/10.1002/smll.202304370
Vancouver
Wei X, Huang H, Guo J, Li N, Li Q, Zhao T, et al. Biomimetic Nano‐Immunoactivator via Ionic Metabolic Modulation for Strengthened NIR‐II Photothermal Immunotherapy. Small. 2023;19(49). doi:10.1002/smll.202304370
BibTeX
@article{Wei2023,
author = {Wei, Xiaodan and Huang, Honglin and Guo, Junhan and Li, Ningxi and Li, Qingzhi and Zhao, Tian and Yang, Geng and Cai, Lulu and Yang, Hong and Wu, Chunhui and Liu, Yiyao},
title = {Biomimetic Nano‐Immunoactivator via Ionic Metabolic Modulation for Strengthened NIR‐II Photothermal Immunotherapy},
journal = {Small},
year = {2023},
volume = {19},
number = {49},
doi = {10.1002/smll.202304370}
}
EUVIMED